橘 直矢 TACHIBANA NAOYA

ID:9000256780716

東京大学医学部付属病院分院麻酔部 Department of Anesthesiology, Faculty of Medicine, University of Tokyo Branch Hospital (1985年 CiNii収録論文より)

Search authors sharing the same name

Articles:  1-1 of 1

  • CLINICAL EVALUATION OF TMS-19-Q·GC TABLET ON SUPERFICIAL SUPPURATIVE DISEASE:A COMPARATIVE DOUBLE BLIND STUDY WITH MIDECAMYCIN  [in Japanese]

    KUKITA ATSUSHI , UENO KAZUE , FUJITA KEIICHI , TEI KEN , TODA KIYOSHI , IMURA MAKOTO , TASHIRO MASAAKI , OKAMOTO MITSUSE , TACHIBANA NAOYA , MORIKAWA NORIKO , NOHARA NOZOMI , NONAMI EIICHIRO , UMEMURA SHIGEO , NOMOTO SHIGERU , WATANABE SHINICHI , HANAWA SHINTARO , HARADA SHOTARO , SATO SHOZO , MERA SHUJI , SHISHIBA TAKAKO , TOMIZAWA TAKANORI , ANZAI TAKASHI , TAGAMI HACHIRO , YAMANO TATSUFUMI , ARAO TATSUYOSHI , NORIMURA TETSUJI , KAGESHITA TOSHIRO , ASADA YASUO , TANITA YASUO , SHIGENO YOICHI , MIURA YUSHO , URABE HARUKUNI , HOSOKAWA HIROSHI , TAKIWAKI HIROTSUGU , TAKAHASHI HISASHI , TSUKINAGA ICHIRO , TAKEDA KATSUYUKI

    新しいMacrolide系抗生剤であるTMS-19-Q·GC錠(TMS)の浅在性皮膚化膿症に対する有効性及び安全性をMidecamycin (MDM)を対照薬として二重盲検法で検討した.投与量はTMS 1 日600mg, MDM 1,200mgで比較を行った.<BR>臨床効果検討症例218例 (TMS 群 106例, MDM 群 112例) での最終全般改善度(かなり改善 …

    The Japanese Journal of Antibiotics 38(5), 1331-1354, 1985

    J-STAGE 

Page Top